Can Medibank Private Ltd continue its success in 2016?

After the latest set of results from Medibank Private Ltd (ASX:MPL), shareholders are surely wondering if the insurer can continue its strong run.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Health insurer Medibank Private Ltd (ASX: MPL) recently grew its half-year profit by 58%, although revenues only lifted 4.6%.

An important driver of health insurance revenues are legislated increases in insurance premiums allocated by the government. In my coverage of Medibank's results I warned readers that future premium increases are likely to be much lower than in the past, as a result of government reluctance to lift premiums by as much as insurers want.

In its recent submission to the Commonwealth review of the healthcare system, Medibank identified several ways to reduce waste in the healthcare system that would likely, as a side effect, result in increased customers for the insurer.

Here are several key recommendations and the potential savings from Medibank's submission:

  • Improve information-sharing for consumers and insurers
  • Standardise simpler products and terminology ($150-$330m p.a.)
  • End cost-shifting from public hospitals to privately insured consumers ($1.05bn p.a.)
  • Introduce reference pricing system to reduce costs of prostheses ($800m p.a.)
  • Reduce hospital default costs ($610m p.a.)
  • Improve competition and premium setting ($200m p.a.)
  • Reward under-30s for early uptake of health insurance ($100m p.a.)

According to Medibank's figures, 500,000 Australians downgraded or cancelled their health insurance in 2015 as a result of spiralling premiums. In 2011-2012, the Australian Bureau of Statistics reported that 9.7 million adults (57% of people aged 18 and over) had private health insurance.

Thus if Medibank's figures are correct, approximately 5% of the total number of private health customers reduced or cancelled their cover in 2015. This is a big hit and appears to confirm Medibank's own assertion that affordability is 'becoming critical' for customers.

Depending on the change to statistics since 2012, there could also be room for growth in the total number of individuals with private health insurance. With up to $3bn in waste to be cut from the system, lower costs should entice a number of lapsed and even new members to improve their private health cover.

Additional initiatives such as discounts for under-30s, superannuation-style programs that pay premiums after retirements, and insurance products that provide rest-of-life cover for an up-front payment could potentially draw many more customers into the private health insurance sphere.

So while Medibank and other insurers may not expect great premium increases in coming years, there appears to be plenty of room for them to grow revenues by attracting more customers. The caveat is that some or none of the proposed changes to the healthcare system may make it off the drawing board.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »